PACIRA BIOSCIENCES, INC. Share Repurchase Authorization
PACIRA BIOSCIENCES, INC. (PCRX) had Share Repurchase Authorization of $300.00 million as of 2025-04-17, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Equity
srt:StockRepurchaseProgramAuthorizedAmount1 · last filed 2026-08-04
- 2025-04-17: Stock Repurchase Program Authorized Amount1 $300.00M.
- 2024-05-08: Stock Repurchase Program Authorized Amount1 $150.00M.
- 2024-05-07: Stock Repurchase Program Authorized Amount1 $150.00M.
| Period end | Stock Repurchase Program Authorized Amount1 |
|---|---|
| 2025-04-17 | $300.00M 10-Q · filed 2026-08-04 |
| 2024-05-08 | $150.00M 10-K · filed 2025-02-27 |
| 2024-05-07 | $150.00M 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |